Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Acidic pH via NF-κB favours VEGF-C expression in human melanoma cells.

Peppicelli S, Bianchini F, Contena C, Tombaccini D, Calorini L.

Clin Exp Metastasis. 2013 Dec;30(8):957-67. doi: 10.1007/s10585-013-9595-4. Epub 2013 Jun 20.

PMID:
23784694
2.

Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma.

Liu B, Ma J, Wang X, Su F, Li X, Yang S, Ma W, Zhang Y.

Anat Rec (Hoboken). 2008 Oct;291(10):1227-35. doi: 10.1002/ar.20736.

3.

Vascular endothelial growth factor-C expression correlates with lymph node localization of human melanoma metastases.

Schietroma C, Cianfarani F, Lacal PM, Odorisio T, Orecchia A, Kanitakis J, D'Atri S, Failla CM, Zambruno G.

Cancer. 2003 Aug 15;98(4):789-97.

4.

Correlation of NF-kappaB signal pathway with tumor metastasis of human head and neck squamous cell carcinoma.

Yan M, Xu Q, Zhang P, Zhou XJ, Zhang ZY, Chen WT.

BMC Cancer. 2010 Aug 17;10:437. doi: 10.1186/1471-2407-10-437.

5.
6.

[Study of the correlation between HER-2 gene and lymphangiogenesis and their prognostic significance in human breast cancer].

Zhang GH, Yang WT, Zhou XY, Zeng Y, Lu HF, Shi DR.

Zhonghua Yi Xue Za Zhi. 2007 Jan 16;87(3):155-60. Chinese.

PMID:
17425844
7.

Stromal expression of vascular endothelial growth factor C is relevant to predict sentinel lymph node status in melanomas.

Gallego E, Vicioso L, Alvarez M, Hierro I, Pérez-Villa L, Blanes A, Matilla A.

Virchows Arch. 2011 May;458(5):621-30. doi: 10.1007/s00428-011-1044-7. Epub 2011 Jan 29.

PMID:
21279519
8.

Peritumoral lymphangiogenesis induced by vascular endothelial growth factor C and D promotes lymph node metastasis in breast cancer patients.

Zhao YC, Ni XJ, Li Y, Dai M, Yuan ZX, Zhu YY, Luo CY.

World J Surg Oncol. 2012 Aug 20;10:165. doi: 10.1186/1477-7819-10-165.

9.
10.

Different patterns of NF-κB and Notch1 signaling contribute to tumor-induced lymphangiogenesis of esophageal squamous cell carcinoma.

Su C, Chen Z, Luo H, Su Y, Liu W, Cai L, Wang T, Lei Y, Zhong B.

J Exp Clin Cancer Res. 2011 Sep 22;30:85. doi: 10.1186/1756-9966-30-85.

11.

Tumor lymphangiogenesis and melanoma metastasis.

Rinderknecht M, Detmar M.

J Cell Physiol. 2008 Aug;216(2):347-54. doi: 10.1002/jcp.21494. Review.

PMID:
18481261
12.

Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma.

Guo B, Zhang Y, Luo G, Li L, Zhang J.

Anat Rec (Hoboken). 2009 May;292(5):633-9. doi: 10.1002/ar.20893.

13.

Vascular endothelial growth factor-C and vascular endothelial growth factor-d messenger RNA expression in breast cancer: association with lymph node metastasis.

Koyama Y, Kaneko K, Akazawa K, Kanbayashi C, Kanda T, Hatakeyama K.

Clin Breast Cancer. 2003 Dec;4(5):354-60.

PMID:
14715111
14.

Rapamycin, a specific inhibitor of the mammalian target of rapamycin, suppresses lymphangiogenesis and lymphatic metastasis.

Kobayashi S, Kishimoto T, Kamata S, Otsuka M, Miyazaki M, Ishikura H.

Cancer Sci. 2007 May;98(5):726-33.

15.
16.

Peroxiredoxin 1 stimulates endothelial cell expression of VEGF via TLR4 dependent activation of HIF-1α.

Riddell JR, Maier P, Sass SN, Moser MT, Foster BA, Gollnick SO.

PLoS One. 2012;7(11):e50394. doi: 10.1371/journal.pone.0050394. Epub 2012 Nov 21.

17.

Relationship between cyclooxygenase-2 and human epidermal growth factor receptor 2 in vascular endothelial growth factor C up-regulation and lymphangiogenesis in human breast cancer.

Bhattacharjee RN, Timoshenko AV, Cai J, Lala PK.

Cancer Sci. 2010 Sep;101(9):2026-32. doi: 10.1111/j.1349-7006.2010.01647.x. Erratum in: Cancer Sci. 2010 Oct;101(10):2293.

18.

Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma.

Niki T, Iba S, Tokunou M, Yamada T, Matsuno Y, Hirohashi S.

Clin Cancer Res. 2000 Jun;6(6):2431-9.

19.

Potential implication of IL-24 in lymphangiogenesis of human breast cancer.

Frewer NC, Ye L, Sun PH, Owen S, Ji K, Frewer KA, Hargest R, Jiang WG.

Int J Mol Med. 2013 May;31(5):1097-104. doi: 10.3892/ijmm.2013.1319. Epub 2013 Mar 27.

PMID:
23546515
20.

Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling.

He Y, Kozaki K, Karpanen T, Koshikawa K, Yla-Herttuala S, Takahashi T, Alitalo K.

J Natl Cancer Inst. 2002 Jun 5;94(11):819-25.

PMID:
12048269

Supplemental Content

Support Center